ZOLEDRONATE IN PAGET'S DISEASE

  • Siris, Ethel (PI)

Project: Research project

Project Details

Description

This is an open label transdermal study of zoledronate at several doses in patients with active Paget's disease. Patients will be monitored for efficacy through use of biomarkers of bone turnover in blood and urine. Tolerability of skin patches and safety of the agent will be assessed through frequent patient visits.
StatusFinished
Effective start/end date10/1/979/30/99

Funding

  • National Center for Research Resources

ASJC Scopus Subject Areas

  • Cancer Research

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.